Global bioscience company Chr. Hansen has expanded its strain library of potential microbiome modulating strains. [ + ]

In the world's largest study into the genetic causes of endometriosis, researchers have helped identify five new gene regions linked to the disease. [ + ]

Using a combination of bioengineering and stem cell culture, scientists have formed brain-like structures called organoids that resemble the shape of a human embryo. [ + ]

The NovaSeq genome sequencing platform, based at the Victorian Comprehensive Cancer Centre, is expected to revolutionise the detection, diagnosis and treatment of cancer and rare genetic disease through rapid and efficient genome analysis. [ + ]

Q-Sera has developed a blood collection tube which rapidly produces high-quality serum for testing. The secret to the company's success? Proteins sourced from the venom of the Australian Coastal Taipan. [ + ]

The NSW Government will continue its involvement in collaborative invasive species research and innovation under the new Centre for Invasive Species Solutions, while the Plant Biosecurity CRC is celebrating a win for its Pestpoint software at Collaborate | Innovate 2017. [ + ]

Three Australian start-up companies have just returned from a four-month stay at the Texas Medical Center (TMC) — the largest medical centre in the world. [ + ]

Monash University has signed a multiyear research and commercialisation deal with Janssen Biotech for the early detection and prevention of rheumatoid arthritis. [ + ]

Zelda Therapeutics has announced positive results from its ongoing preclinical research into the use of cannabinoids as anticancer agents. [ + ]

Researchers at CSIRO's Data61 are developing a software tool that could significantly improve the detection of the development of new blood vessels, which is known to precede the growth of cancers. [ + ]

OncoRes Medical, established to develop an imaging tool to improve the outcome of breast cancer surgery, will receive up to $6 million of venture capital investment from the Medical Research Commercialisation Fund (MRCF). [ + ]

Avita Medical has announcement the appointment of Dr Michael Perry as its new CEO, as well as the results of a US pivotal burns trial. [ + ]

MTPConnect Chief Executive Officer Sue MacLeman has been awarded BioMelbourne Network's 2017 Women in Leadership award. [ + ]

Researchers from The Netherlands have developed a glass microchip for ultrafast separation and purification of DNA fragments. [ + ]

British intellectual property commercialisation company IP Group has signed agreements with nine Australasian universities to invest $200 million in finding and developing companies involved in disruptive innovation. [ + ]